I had a long wait for the Red Line and a gratis NY Times from the BU Comm school. So, I read this piece about the FDA doc who is trying to protect patients from marginally useful cancer drugs. Dr. Richard Pazdur, director of the Food and Drug Administration’s cancer drug office "has helped to … Continue reading FDA doc takes heat for strict standards on new cancer drugs
FROM MIT: Many of us take daily medications for conditions such as high cholesterol or hypertension, but in the face of constant advertising of prescription medications, it’s easy to wonder: is there something newer and better I should be taking? Physician panelists at “Ask Your Doctor"... Medications, Marketing and Safety on May 14 will share … Continue reading What patients should know about marketing of meds: May 14 MIT event
Former NEJM editor and pharma critic Marcia Angell offers her advice on reforming the FDA on today's Globe op-ed page. It is time to restore the FDA to its purpose, which is to protect the public from unsafe food, drugs, and devices, not to accommodate the industries it regulates. The change in leadership is reason … Continue reading Marcia Angell on the FDA
Health Wonk Review is a "roving digest" of notable blogs entries about health policy. This week, Medicaid Front Page hosts, with an entry that would make my comics-reading son happy - The "Watchmen Edition." Each entry is linked to one of the superheroes in this movie, which is opens today. (My contribution earned Dr. Jim Kim a Nite … Continue reading Can the Watchmen save Boston doctors from conflicts of interest?
Big Supreme Court ruling. This from The Washington Post site: The Supreme Court today ruled in favor of a woman who had her arm amputated after an improper injection of an antinausea drug and said drugmakers could not rely on federal regulation to protect them from lawsuits brought under state consumer protection laws. The court ruled … Continue reading Vermont link to Supreme Court ruling on FDA liability